对异位生物功能降解剂诱导的PTPN2/N1复合体的机制性见解
Qi Hao1, Manoj K Rathinaswamy2, Kelly L Klinge3
1Calico Life Sciences LLC, South San Francisco, CA, 94080, USA. qhao@calicolabs.com.
Communications chemistry
|August 16, 2024
概括
我们开发了针对PTPN2和PTPN1酸酶的新型双降解剂,增强免疫治疗反应. 结构研究揭示了这些降解剂如何诱导蛋白质-蛋白质相互作用,以向癌症的降解.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 免疫学 免疫学 免疫学
背景情况:
- PTPN2和PTPN1是关键的酸酶和有吸引力的免疫瘤学点.
- 有针对性的蛋白质降解为具有挑战性的酸酶等标提供了一种新的治疗策略.
- 删除Ptpn1和Ptpn2在临床前模型中改善免疫疗法反应方面表现有前途.
研究的目的:
- 为了开发强大的PTPN2/N1双重异构功能降解剂.
- 阐明对降解剂诱导的合作复合体形成的机制性见解.
- 提供对涉及降解剂,E3结合酶和酸酶目标的三元复合物的结构理解.
主要方法:
- 新型异位生物功能降解剂 (Cmpd-1和Cmpd-2) 的开发.
- 利用X射线晶体学来确定与降解剂结合的PTPN2的结构.
- 使用单粒子冷电子显微镜 (cryo-EM) 来解析DDB1-CRBN/Cmpd-1/PTPN2复合体.
- 基于冷EM数据进行了分子动力学 (MD) 模拟.
主要成果:
- 成功开发出强大的PTPN2/N1双降解剂 (Cmpd-1,Cmpd-2),在细胞和小鼠中调解降解.
- 晶体结构显示了降解剂对PTPN2的特定识别.
- 低温EM结构阐明了CRBN和PTPN2之间的降解剂诱导的近距离,尽管它们的形状异质.
- MD模拟突出了三元复合体内的动态相互作用和刚性身体运动.
结论:
- 证明了PTPN2/N1异构功能降解剂的发展,具有癌症免疫疗法的潜力.
- 结构工作流提供了对降解器诱导的三元复合体的动态性质的洞察.
- 这些降解剂代表了在免疫瘤学中向酸酶的有希望的方法.
更多相关视频
相关概念视频
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome
819
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
819
Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


